{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T19:48:35Z","timestamp":1789069715381,"version":"build-2803163510"},"reference-count":33,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","dldjournalonline.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Digestive and Liver Disease"],"published-print":{"date-parts":[[2024,3]]},"DOI":"10.1016\/j.dld.2023.09.012","type":"journal-article","created":{"date-parts":[[2023,9,29]],"date-time":"2023-09-29T16:16:49Z","timestamp":1696004209000},"page":"477-483","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"title":["Bacterial infections as a risk factor for non-neoplastic portal vein thrombosis development in cirrhotic patients"],"prefix":"10.1016","volume":"56","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0402-4176","authenticated-orcid":false,"given":"Andrea","family":"Dalbeni","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Filippo","family":"Cattazzo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leonardo","family":"De Marco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michele","family":"Bevilacqua","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mirko","family":"Zoncap\u00e8","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rosa","family":"Lombardi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roberta","family":"Stupia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Mantovani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Sacerdoti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"6","key":"10.1016\/j.dld.2023.09.012_bib0001","doi-asserted-by":"crossref","first-page":"1367","DOI":"10.1016\/j.jhep.2021.07.020","article-title":"Predicting portal thrombosis in cirrhosis: a prospective study of clinical, ultrasonographic and hemostatic factors","volume":"75","author":"Turon","year":"2021","journal-title":"J Hepatol"},{"issue":"19","key":"10.1016\/j.dld.2023.09.012_bib0002","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1172\/jci.insight.94416","article-title":"Microbiota, cirrhosis, and the emerging oral-gut-liver axis","volume":"2","author":"Acharya","year":"2017","journal-title":"JCI Insight"},{"issue":"9","key":"10.1016\/j.dld.2023.09.012_bib0003","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1016\/j.cgh.2011.02.031","article-title":"Immune dysfunction and infections in patients with cirrhosis","volume":"9","author":"Bonnel","year":"2011","journal-title":"Clin Gastroenterol Hepatol [Internet]"},{"issue":"1","key":"10.1016\/j.dld.2023.09.012_bib0004","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1002\/hep.21443","article-title":"Renal failure and bacterial infections in patients with cirrhosis: epidemiology and clinical features","volume":"45","author":"Fasolato","year":"2007","journal-title":"Hepatology"},{"issue":"2","key":"10.1016\/j.dld.2023.09.012_bib0005","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1016\/j.jhep.2020.07.046","article-title":"Clinical features and evolution of bacterial infection-related acute-on-chronic liver failure","volume":"74","author":"Wong","year":"2021","journal-title":"J Hepatol"},{"issue":"9","key":"10.1016\/j.dld.2023.09.012_bib0006","doi-asserted-by":"crossref","DOI":"10.3390\/jcm9092822","article-title":"Portal thrombosis in cirrhosis: role of thrombophilic disorders","volume":"9","author":"Fortea","year":"2020","journal-title":"J Clin Med"},{"issue":"3","key":"10.1016\/j.dld.2023.09.012_bib0007","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1001\/jama.2014.18229","article-title":"Association between hospitalization for pneumonia and subsequent risk of cardiovascular disease","volume":"313","author":"Corrales-Medina","year":"2015","journal-title":"JAMA"},{"key":"10.1016\/j.dld.2023.09.012_bib0008","article-title":"Long-term risk and predictors of cerebrovascular events following sepsis hospitalization: a systematic review and meta-analysis","volume":"9","author":"Arero","year":"2022","journal-title":"Front Med (Lausanne)"},{"issue":"2","key":"10.1016\/j.dld.2023.09.012_bib0009","doi-asserted-by":"crossref","first-page":"e49","DOI":"10.1016\/j.jemermed.2019.02.010","article-title":"Concomitant infection with Epstein-Barr virus and cytomegalovirus infection leading to portal vein thrombosis","volume":"57","author":"Hyakutake","year":"2019","journal-title":"J Emerg Med"},{"issue":"3","key":"10.1016\/j.dld.2023.09.012_bib0010","doi-asserted-by":"crossref","first-page":"e286","DOI":"10.1055\/s-0041-1730967","article-title":"Venous thromboembolism in hospitalized critical and noncritical COVID-19 patients: a systematic review and meta-analysis","volume":"5","author":"Mansory","year":"2021","journal-title":"TH Open"},{"key":"10.1016\/j.dld.2023.09.012_bib0011","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.medcli.2017.07.013","article-title":"Asymptomatic portal vein thrombosis associated to acute cytomegalovirus infection in an immunocompetent patient","volume":"150","author":"Mendoza Lizardo","year":"2018","journal-title":"Med Clin (Barc)"},{"issue":"7","key":"10.1016\/j.dld.2023.09.012_bib0012","article-title":"Global hemostatic profiling in patients with decompensated cirrhosis and bacterial infections","volume":"4","author":"Zanetto","year":"2022","journal-title":"JHEP Rep"},{"issue":"6","key":"10.1016\/j.dld.2023.09.012_bib0013","doi-asserted-by":"crossref","first-page":"878","DOI":"10.1182\/blood-2010-02-261891","article-title":"Rebalanced hemostasis in patients with liver disease: evidence and clinical consequences","volume":"116","author":"Lisman","year":"2010","journal-title":"Blood"},{"issue":"8","key":"10.1016\/j.dld.2023.09.012_bib0014","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1001\/jama.2016.0287","article-title":"The third international consensus definitions for sepsis and septic shock (Sepsis-3)","volume":"315","author":"Singer","year":"2016","journal-title":"JAMA"},{"issue":"May","key":"10.1016\/j.dld.2023.09.012_bib0015","first-page":"22","article-title":"Annual epidemiological report for 2019 \u2013 healthcare- associated infections acquired in intensive care units","volume":"46","year":"2023","journal-title":"ECDC Ann Epidemiol Rep [Internet]"},{"key":"10.1016\/j.dld.2023.09.012_bib0016","series-title":"StatPearls [Internet]","author":"Monegro","year":"2023"},{"issue":"5","key":"10.1016\/j.dld.2023.09.012_bib0017","doi-asserted-by":"crossref","first-page":"1551","DOI":"10.1002\/hep.25532","article-title":"Prevalence and risk factors of infections by multiresistant bacteria in cirrhosis: a prospective study","volume":"55","author":"Fern\u00e1ndez","year":"2012","journal-title":"Hepatology"},{"key":"10.1016\/j.dld.2023.09.012_bib0018","unstructured":"Hughes R.G. Patient safety and quality: an evidence-based handbook for nurses. Hughes RG, editor Rockville (MD): Agency for Healthcare Research and Quality (US); 2008."},{"issue":"3","key":"10.1016\/j.dld.2023.09.012_bib0019","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1002\/1097-0142(20010201)91:3<561::AID-CNCR1035>3.0.CO;2-N","article-title":"Des-gamma-carboxy prothrombin as a useful predisposing factor for the development of portal venous invasion in patients with hepatocellular carcinoma: a prospective analysis of 227 patients","volume":"91","author":"Koike","year":"2001","journal-title":"Cancer"},{"issue":"August 2022","key":"10.1016\/j.dld.2023.09.012_bib0020","article-title":"Gut dysbiosis, endotoxemia and clotting activation: a dangerous trio for portal vein thrombosis in cirrhosis","volume":"57","author":"Violi","year":"2023","journal-title":"Blood Rev [Internet]"},{"issue":"10","key":"10.1016\/j.dld.2023.09.012_bib0021","doi-asserted-by":"crossref","first-page":"1870","DOI":"10.1136\/gutjnl-2017-314240","article-title":"Bacterial and fungal infections in acute-on-chronic liver failure: prevalence, characteristics and impact on prognosis","volume":"67","author":"Fern\u00e1ndez","year":"2018","journal-title":"Gut"},{"issue":"16","key":"10.1016\/j.dld.2023.09.012_bib0022","doi-asserted-by":"crossref","first-page":"e25439","DOI":"10.1097\/MD.0000000000025439","article-title":"Effect of portal vein thrombosis on the prognosis of patients with cirrhosis without a liver transplant: a systematic review and meta-analysis","volume":"100","author":"Xian","year":"2021","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.dld.2023.09.012_bib0023","doi-asserted-by":"crossref","first-page":"6769","DOI":"10.3748\/wjg.v21.i22.6769","article-title":"Portal vein thrombosis in cirrhosis: controversies and latest developments","volume":"21","author":"Harding","year":"2015","journal-title":"World J Gastroenterol"},{"issue":"4","key":"10.1016\/j.dld.2023.09.012_bib0024","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.114.000933","article-title":"The impact of acute kidney injury on the long-term risk of stroke","volume":"3","author":"Wu","year":"2014","journal-title":"J Am Heart Assoc"},{"issue":"6","key":"10.1016\/j.dld.2023.09.012_bib0025","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1055\/s-0040-1715473","article-title":"New insights into the pathogenesis, risk factors, and treatment of portal vein thrombosis in patients with cirrhosis","volume":"46","author":"Nicoar\u0103-Farc\u0103u","year":"2020","journal-title":"Semin Thromb Hemost"},{"issue":"18","key":"10.1016\/j.dld.2023.09.012_bib0026","doi-asserted-by":"crossref","DOI":"10.3390\/ijms231810900","article-title":"The controversial role of LPS in platelet activation in vitro","volume":"23","author":"Galgano","year":"2022","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.dld.2023.09.012_bib0027","doi-asserted-by":"crossref","DOI":"10.3389\/fcimb.2022.897019","article-title":"Neutrophil extracellular traps induced by shiga toxin and lipopolysaccharide-treated platelets exacerbate endothelial cell damage","volume":"12","author":"Landoni","year":"2022","journal-title":"Front Cell Infect Microbiol"},{"issue":"8","key":"10.1016\/j.dld.2023.09.012_bib0028","doi-asserted-by":"crossref","first-page":"1459","DOI":"10.1111\/liv.14121","article-title":"Incidence, predictive factors and clinical significance of development of portal vein thrombosis in cirrhosis: a prospective study","volume":"39","author":"Noronha Ferreira","year":"2019","journal-title":"Liver Int"},{"key":"10.1016\/j.dld.2023.09.012_bib0029","article-title":"Type of infection is associated with prognosis in acute-on-chronic liver failure: a national veterans health administration study","author":"Mahmud","year":"2022","journal-title":"Dig Dis Sci"},{"issue":"32","key":"10.1016\/j.dld.2023.09.012_bib0030","doi-asserted-by":"crossref","first-page":"7289","DOI":"10.3748\/wjg.v22.i32.7289","article-title":"Management of hepatocellular carcinoma with portal vein tumor thrombosis: review and update at 2016","volume":"22","author":"Chan","year":"2016","journal-title":"World J Gastroenterol"},{"issue":"1","key":"10.1016\/j.dld.2023.09.012_bib0031","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1007\/s10585-022-10188-1","article-title":"Portal vein tumor thrombosis in hepatocellular carcinoma: molecular mechanism and therapy","volume":"40","author":"Zhou","year":"2023","journal-title":"Clin Exp Metastasis"},{"key":"10.1016\/j.dld.2023.09.012_bib0032","article-title":"Contact system activation and neutrophil extracellular trap markers: risk factors for portal vein thrombosis in patients with hepatocellular carcinoma","volume":"25","author":"do","year":"2019","journal-title":"Clin Appl Thromb Hemost"},{"issue":"2\u20133","key":"10.1016\/j.dld.2023.09.012_bib0033","article-title":"Rivaroxaban improves survival and decompensation in cirrhotic patients with moderate liver dysfunction. Double-blind, placebo-controlled trial","volume":"78","author":"Puente Sanchez","year":"2023","journal-title":"J Hepatol"}],"container-title":["Digestive and Liver Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S159086582300957X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S159086582300957X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,28]],"date-time":"2025-10-28T04:24:35Z","timestamp":1761625475000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S159086582300957X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,3]]},"references-count":33,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2024,3]]}},"alternative-id":["S159086582300957X"],"URL":"https:\/\/doi.org\/10.1016\/j.dld.2023.09.012","relation":{},"ISSN":["1590-8658"],"issn-type":[{"value":"1590-8658","type":"print"}],"subject":[],"published":{"date-parts":[[2024,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Bacterial infections as a risk factor for non-neoplastic portal vein thrombosis development in cirrhotic patients","name":"articletitle","label":"Article Title"},{"value":"Digestive and Liver Disease","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.dld.2023.09.012","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Editrice Gastroenterologica Italiana S.r.l. Published by Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}